References
Cohen TJ, Lee VMY, Trojanowski JQ (2011) TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med 17:659–667
Engler H, Santillo AF, Wang SX, Lindau M, Savitcheva I, Nordberg A, Lannfelt L, Langstom B, Kilander L (2008) In vivo amyloid imaging with PET in frontotemporal dementia. Eur J Nucl Med Mol Imaging 35:100–106
Guo W, Chen Y, Zhou X, Kar A, Ray P, Chen X, Rao EJ, Yang M, Ye H, Zhu L, Liu J, Zhang D, Buratti E, Baralle FE, Bigio EH, Mesulam M, Xu Q, Shen Y, Fushimi K, Wu JY (2011) An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxocity. Nat Struct Mol Biol 18:822–830
Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang G, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B (2004) Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B. Ann Neurol 55:306–319
Lee EB, Lee VM-Y, Trojanowski JQ (2012) Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nature 13:38–50
Robinson JL, Geser F, Stieber A, Umoh M, Kwong LK, Van Deerlin VM, Lee VM-Y, Trojanowski JQ (2013) TDP-43 skeins show properties of amyloid in a subset of ALS cases. Acta Neuropathol 125:121–131. doi:10.1007/s00401-012-1055-8
Westermark GT, Johnson KH, Westermark P (1999) Staining methods for identification of amyloid in tissue. Methods Enzymol 309:3–25
Wolozin B (2012) Regulated protein aggregation: stress granules and neurodegeneration. Mol Neurodegener 7:56. doi:10.1186/1750-1326-7-56
Acknowledgments
Support from the following is acknowledged: EHB, MM, CG, RG, and MP, NIA AG 13854; JYW, NIA (RO1AG033004), NINDS (R56NS074763) and ALS Therapy Alliance. H-XD, NIH NS078287, NS081474, NS074366; TS, NS078504, NS082104.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bigio, E.H., Wu, J.Y., Deng, HX. et al. Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid. Acta Neuropathol 125, 463–465 (2013). https://doi.org/10.1007/s00401-013-1089-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-013-1089-6